In vitro blockade of adhesion of breast cancer cells to endothelial cells using anti-inflammatory drugs.

Abstract:

BACKGROUND:Increasing evidence suggests that a pro-inflammatory microenvironment affects distant metastasis of breast cancer cells, in particular by favoring tumor cell adhesion to endothelium. The aim of this study was to investigate the potential of different anti-inflammatory drugs to inhibit this effect in vitro. MATERIALS AND METHODS:Breast cancer cells from the metastatic cell line KM22 were incubated with activated Human umbilical vein endothelial cells (HUVECs). Tumor cell adhesion was quantified by fluorescence microscopy. The anti-inflammatory drugs ibuprofen, aspirin (acetylsalicylic acid), diclofenac, and dexamethasone were used as inhibiting agents. RESULTS:Aspirin and dexamethasone significantly reduced breast cancer cell adhesion to HUVECs (20.3%, p<0.000; and 25%, p<0.05, respectively). Ibuprofen and diclofenac did not significantly reduce tumor cell adhesion. CONCLUSION:Aspirin and dexamethasone seem to be able to partly inhibit adhesion of breast cancer cells to endothelium. Future studies should attempt to optimize this effect in vitro, in preparation for potential in vivo trials.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Bischofs E,Lubs D,Fritzsche F,Meyer AS,Bruckner T,Sohn C,Eichbaum MH

subject

Has Abstract

pub_date

2012-03-01 00:00:00

pages

767-71

issue

3

eissn

0250-7005

issn

1791-7530

pii

32/3/767

journal_volume

32

pub_type

杂志文章
  • Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma.

    abstract::Twenty-seven children with abdominal Burkitt's lymphoma (stage III), who had achieved complete remission, were entered into a prospective controlled trial of adjunct treatment with Epstein-Barr virus (EBV)-specific transfer factor (TF). Two patients treated with TF and 2 controls relapsed early (less than or equal to ...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Neequaye J,Viza D,Pizza G,Levine PH,De Vinci C,Ablashi DV,Biggar RJ,Nkrumah FK

    更新日期:1990-09-01 00:00:00

  • Vitamin D favorably alters the cancer promoting prostaglandin cascade.

    abstract:BACKGROUND:Preclinical studies suggest that 1,25-dihydroxyvitamin D [1,25(OH)2D] and celecoxib inhibit prostaglandins (PGs) associated with cancer through different mechanisms. We determined if there was synergy in their use. PATIENTS AND METHODS:A total of 36 healthy women received daily for one month/menstrual cycle...

    journal_title:Anticancer research

    pub_type: 杂志文章,随机对照试验

    doi:

    authors: Qin W,Smith C,Jensen M,Holick MF,Sauter ER

    更新日期:2013-09-01 00:00:00

  • Clinicoradiological Features of Recurrent Meningioma With High Grade Transformation.

    abstract:BACKGROUND/AIM:A minority of grade I meningiomas (MG1s) recur after surgical resection and their progression is associated with high grade transformation (HGT). This study aimed to characterize the clinicoradiological features of recurrent MGs (RMG) with HGT. PATIENTS AND METHODS:We identified 17 patients diagnosed wi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13840

    authors: Yeon EK,Sung JY,DO SI,Park BJ,Kim EJ,Na K

    更新日期:2019-11-01 00:00:00

  • The Role of Re-resection for Breast Cancer Liver Metastases-a Single Center Experience.

    abstract:UNLABELLED:The aim of the present study was to evaluate the effectiveness and safety of hepatic re-resection for breast cancer liver metastases. PATIENTS AND METHODS:Between January 2004 and December 2014 seven patients were submitted to liver re-resection for breast cancer liver metastases at our Center. The main inc...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: BacalbaȘa N,Balescu I,Dima S,Popescu I

    更新日期:2015-12-01 00:00:00

  • Antitumor activity of cytotropic heterogeneous molecular lipids (CHML) on human breast cancer xenograft in nude mice.

    abstract::Cytotropic heterogeneous molecular lipid (CHML), which is a new anticancer agent with US patent number 5,260,067, has recently been shown to suppress tumor cell growth in multiple tumor lines and induce apoptosis in vitro (1). These results indicate that CHML may be an effective antitumor agent. In the present study, ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Zhan Q,Zhao SC,Xu Z

    更新日期:2001-07-01 00:00:00

  • Different Gene Expression and Activity Pattern of Antioxidant Enzymes in Bladder Cancer.

    abstract::The aim of this study was to evaluate the possible role in and contribution of antioxidant enzymes to bladder cancer (BC) etiology and recurrence after transurethral resection (TUR). We enrolled 40 patients with BC who underwent TUR and 100 sex- and age-matched healthy controls. The analysis was performed at diagnosis...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11387

    authors: Wieczorek E,Jablonowski Z,Tomasik B,Gromadzinska J,Jablonska E,Konecki T,Fendler W,Sosnowski M,Wasowicz W,Reszka E

    更新日期:2017-02-01 00:00:00

  • Evaluation of a possible styrene-induced damage to the haematopoietic tissues in the rat.

    abstract::The aim of this study was to determine a possible risk of malignancies in the haematopoietic tissues of rats treated with styrene, either by injection or by inhalation. Two experiments were carried out: in the first (acute treatment), 12 male rats were treated intraperitoneally with different doses of styrene (40 mg/K...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nano R,Rossi A,Fenoglio C,de Piceis Polver P

    更新日期:2000-05-01 00:00:00

  • Suppressor microRNA-145 Is Epigenetically Regulated by Promoter Hypermethylation in Esophageal Squamous Cell Carcinoma.

    abstract:BACKGROUND/AIM:DNA methylation is a common epigenetic change in cancer. However, microRNA (miRNA) regulation by epigenetic alteration, especially CpG island hypermethylation, remains poorly understood in esophageal squamous cell carcinoma (ESCC). MATERIALS AND METHODS:miRNAs which were up-regulated after de-methylatio...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Harada K,Baba Y,Ishimoto T,Kosumi K,Tokunaga R,Izumi D,Ohuchi M,Nakamura K,Kiyozumi Y,Kurashige J,Iwagami S,Miyamoto Y,Sakamoto Y,Yoshida N,Oki E,Watanabe M,Baba H

    更新日期:2015-09-01 00:00:00

  • Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation.

    abstract:BACKGROUND:Cancer-related acute disseminated intravascular coagulation (DIC) is uncommon, but it is a severe complication resulting in a very dismal prognosis. Choosing the appropriate chemotherapy agents to treat the underlying cancer and stop the acute DIC process effectively, while avoiding chemotherapy-induced myel...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lin PH,Lu YS,Lin CH,Chang DY,Huang CS,Cheng AL,Yeh KH

    更新日期:2010-07-01 00:00:00

  • Clinical outcomes after first-line EGFR inhibitor treatment for patients with NSCLC, EGFR mutation, and poor performance status.

    abstract:BACKGROUND:The phase II NEJ001 trial suggested that gefitinib was active against advanced non-small cell lung cancer (NSCLC) even in patients with poor performance status (PS). Clinical response among the patients harboring epidermal growth factor receptor (EGFR) mutation with poor PS is fair; however, gefitinib does n...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Okuma Y,Hosomi Y,Nagamata M,Yamada Y,Sekihara K,Kato K,Hishima T,Okamura T

    更新日期:2013-11-01 00:00:00

  • Fluorodeoxyglucose Uptake in Advanced Non-small Cell Lung Cancer With and Without Pulmonary Lymphangitic Carcinomatosis.

    abstract:AIM:To assess the correlation between advanced non-small cell lung cancer (NSCLC) with or without pulmonary lymphangitic carcinomatosis (PLC) and fluorodeoxyglucose (FDG) uptake and its effect on survival outcomes. PATIENTS AND METHODS:We retrospectively reviewed 157 patients with NSCLC. The mean and maximum standardi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ooi H,Chen CY,Hsiao YC,Huang WS,Hsieh BT

    更新日期:2016-08-01 00:00:00

  • Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial.

    abstract::22 patients with advanced non-small-cell lung cancer were randomized to receive chemotherapy (ifosfamide) or chemotherapy followed by thymosin alpha1 + low-dose IFNalpha. Chemo-immunotherapy induced an enhanced response rate compared with chemotherapy alone (33% and 10% respectively). Although these differences were n...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Salvati F,Rasi G,Portalone L,Antilli A,Garaci E

    更新日期:1996-03-01 00:00:00

  • In vitro and in vivo interactions of D-penicillamine with tumors.

    abstract::D-penicillamine (PSH) is a copper chelator that generates hydrogen peroxide and inhibits neovascularization. As hydrogen peroxide is toxic to some tumor cells and to blood vessels, we reasoned that PSH plus copper would inhibit tumors in vivo and in vitro. To test this hypothesis, we first incubated murine J558L plasm...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Samoszuk M,Nguyen V

    更新日期:1996-05-01 00:00:00

  • Serum proteinase activities in head and neck squamous cell carcinoma patients.

    abstract::Proteinases are known to be involved in carcinogenesis, and various substrates are now available to measure the activity of these enzymes. No suitable serum tumour marker for head and neck squamous cell carcinoma (HNSCC) exists at this moment. Therefore, we compared proteinase-activity in serum of 20 untreated HNSCC p...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bongers V,Konings CH,Grijpma AM,Steen I,Braakhuis BJ,Snow GB

    更新日期:1995-11-01 00:00:00

  • CA125 based diagnosis and therapy in recurrent ovarian cancer.

    abstract::Approximately 85% of patients with advanced ovarian cancer will experience recurrence of the disease. In 311 patients CA125 serum levels were determined at follow up investigation in our department. A sensitivity of 92% and specificity of 89% were calculated. Reflecting the further course of disease, specificity could...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Meier W,Baumgartner L,Stieber P,Hasholzner U,Fateh-Moghadam A

    更新日期:1997-07-01 00:00:00

  • Whole-transcriptome analysis reveals established and novel associations with TMPRSS2:ERG fusion in prostate cancer.

    abstract:BACKGROUND/AIM:Shortcomings of current methods of prostate cancer detection call for improved biomarkers. The transmembrane protease, serine 2:ets-related gene (TMPRSS2:ERG) gene fusion leads to the overexpression of ERG, an E-twenty six (ETS) family transcription factor, and is the most prevalent genetic lesion in pro...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chow A,Amemiya Y,Sugar L,Nam R,Seth A

    更新日期:2012-09-01 00:00:00

  • Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrite (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions.

    abstract::The aim of this project was to study the kinetics of both Tl and Tc-99m MIBI in PBM by evaluating tumor to normal tissue ratio in early (E) images acquired within 1/2 hour and delayed (D) images acquired three hours following the i.v. injection of 3 mCi (111 MBq) of Tl and 20 mCi (740 MBq) of MIBI on 2 separate days i...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Omar WS,Eissa S,Moustafa H,Farag H,Ezzat I,Abdel-Dayem HM

    更新日期:1997-05-01 00:00:00

  • EBV Rta-induced IL-6 Promotes Migration of Bystander Tumor Cells Through IL-6R/JAK/STAT3 Pathway In Vitro.

    abstract:BACKGROUND/AIM:Rta, a transactivator of Epstein-Barr virus, is associated with progression of nasopharyngel carcinoma (NPC); however, its mechanism of contribution to the pathogenesis of NPC remains unclear. Interleukin-6 (IL-6), a tumor promoter, is detected in NPC. This in vitro study examined whether and how Rta pro...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14307

    authors: Tung KL,Wu YT,Liu C,Lin SC,Wu CH,Wu SY,Chang Y,Lan YY

    更新日期:2020-06-01 00:00:00

  • Prognostic Factors and Treatment Outcome for Patients with Stage IVB Cervical Cancer.

    abstract:AIM:We report a retrospective evaluation for patients with stage IVB cervical cancer in order to identify survival rates and to improve our current practice. PATIENTS AND METHODS:We analyzed 85 patients with stage IVB cervical cancer. For patients appropriate for radical treatment, a combination of external-beam radio...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Oishi S,Kudaka W,Toita T,Ariga T,Nakamoto T,Wakayama A,Nagai Y,Kaneshima I,Nishihira K,Aoki Y

    更新日期:2016-07-01 00:00:00

  • Proteomic analysis showed down-regulation of nucleophosmin in progressive tumor cells compared to regressive tumor cells.

    abstract::Important strategies against cancer are based on the understanding of the mechanisms of tumor progression. To elucidate alterations regarding tumor progression, we have performed proteomic differential display analysis for the expression of intracellular proteins in the regressive murine fibrosarcoma cell clone QR-32 ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Takenawa T,Kuramitsu Y,Wang Y,Okada F,Tokuda K,Kitagawa T,Ueyama Y,Nakamura K

    更新日期:2013-01-01 00:00:00

  • Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer.

    abstract:AIM:We performed a pharmacokinetic phase I trial of the combination of S-1 granules and nedaplatin for head and neck squamous cell carcinoma (HNSCC). PATIENTS AND METHODS:Patients were treated with both nedaplatin on day 1 at a dose starting at 80 mg/m(2) (level 1) escalating up to 90 mg/m(2) (level 2), and S-1 granul...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hayashi H,Okamoto I,Ueda S,Tanaka K,Okamoto K,Kawakami H,Nishina S,Takeda M,Fujisaka Y,Satoh T,Terao K,Nishimura Y,Doi K,Nakagawa K

    更新日期:2013-12-01 00:00:00

  • Digoxin inhibits neuroblastoma tumor growth in mice.

    abstract:BACKGROUND:Epidemiological data suggest a more favorable outcome of breast carcinoma in women taking cardiac glycosides. This study investigated whether digoxin could inhibit tumor growth in mice. MATERIALS AND METHODS:Tumor growth experiments were done in mice grafted with the neuroblastoma cell lines SH-SY5Y, Neuro-...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Svensson A,Azarbayjani F,Bäckman U,Matsumoto T,Christofferson R

    更新日期:2005-01-01 00:00:00

  • Effect of antitumor agents on cytotoxicity induction by sodium fluoride.

    abstract::We have recently found that sodium fluoride (NaF) induced apoptotic cell death in tumor cell lines. We investigated here whether 6 popular antitumor compounds modify the cytotoxic activity of NaF against human squamous cell carcinoma (HSC-2) and human promyelocytic leukemia (HL-60) cell lines. Cytotoxic concentrations...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Morshed SR,Tokunaga T,Otsuki S,Takayama F,Satoh T,Hashimoto K,Yasui T,Okamura M,Shimada J,Kashimata M,Sakagami H

    更新日期:2003-11-01 00:00:00

  • Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination.

    abstract:BACKGROUND:Medullary thyroid carcinoma (MTC) is a calcitonin-producing tumor of the parafollicular C-cells, accounting for 5-10% of all thyroid tumors. To date, the only effective treatment is the early and total surgical removal of all neoplastic tissue. As the prognosis of patients with advanced MTC, unresectable or ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pfragner R,Skofitsch G,Höger H,Jech M,Rinner B,Siegl V,Niederle B,Gnant M,Friedl J,Stift A

    更新日期:2005-11-01 00:00:00

  • Gastric Lavage Malignant Cells (yGL) and Hypohemoglobinemia (yAnemia) as New Systems of Tumor Regression Grading and Prognostic Prediction for Gastric Cancer After Neoadjuvant Treatment.

    abstract:BACKGROUND/AIM:Although reckoned necessary for survival benefit, neoadjuvant chemotherapy (NAC) of gastric cancer (GC) patients has so far provided questionable results. Consequently, searching for new and clearer systems of response to NAC, post-NAC re-evaluation and prognostic prediction appears essential. The purpos...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13208

    authors: Virgilio E,Giarnieri E,Giovagnoli MR,Montagnini M,Proietti A,D'Urso R,Fegiz A,Mercantini P,Balducci G,Cavallini M

    更新日期:2019-02-01 00:00:00

  • Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts.

    abstract::The compound 317615 x 2HCl, a selective protein kinase Cbeta inhibitor, was not very cytotoxic toward human CaKi1 renal cell carcinoma cells or human HT-29 colon carcinoma cells in monolayer culture. Isobologram analysis was used to determine additivity or synergy of the combination regimens. Exposure of CaKi1 cells t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Teicher BA,Menon K,Alvarez E,Galbreath E,Shih C,Faul MM

    更新日期:2001-09-01 00:00:00

  • Pre-treatment C-reactive protein as a prognostic factor for recurrence after surgical resection of hepatocellular carcinoma.

    abstract:BACKGROUND AND AIMS:We examined the prognostic value of pre-treatment C-reactive protein (CRP) after surgical resection (SR) for hepatocellular carcinoma (HCC). PATIENTS AND METHODS:A total of 298 patients with HCC who underwent SR were analyzed. They were categorized into a CRP-positive group (group A: CRP >0.2 mg/dl...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nishikawa H,Arimoto A,Wakasa T,Kita R,Kimura T,Osaki Y

    更新日期:2013-03-01 00:00:00

  • PCNA--a cell proliferation marker in vocal chord cancer. Part I: Premalignant laryngeal lesions.

    abstract::Laryngeal hyperkeratotic lesions can progress to fully developed malignant carcinoma in some cases. These premalignant lesions are proliferative disorders whose potential for further tumour progression is perhaps difficult to assess by mere histology. Immunostaining with PCNA, a protein correlated with cell proliferat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pignataro LD,Broich G,Lavezzi AM,Biondo B,Ottaviani F

    更新日期:1995-07-01 00:00:00

  • Expression of mRNAs of urocortin and corticotropin-releasing factor receptors in malignant glioma cell lines.

    abstract:BACKGROUND:Urocortin and corticotropin-releasing factors (CRFs) and their receptors are expressed in many organs, including the central nervous system. In this study, the expression of mRNAs of urocortin 1, 2, 3, and CRF and CRF receptors 1 and 2 in malignant glioma, was examined. MATERIALS AND METHODS:The RNAs of hum...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kamada M,Ikeda K,Fujioka K,Akiyama N,Akiyoshi K,Inoue Y,Hanada S,Yamamoto K,Tojo K,Manome Y

    更新日期:2012-12-01 00:00:00

  • Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance.

    abstract:BACKGROUND:Despite receiving post-operative 5-fluorouracil (5-FU)-based chemotherapy, approximately 50% of patients with stage IIIC colon cancer experience recurrence. Currently, no molecular signature can predict response to 5-FU. MATERIALS AND METHODS:Mouse models of colon cancer have been developed and characterize...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hadac JN,Miller DD,Grimes IC,Clipson L,Newton MA,Schelman WR,Halberg RB

    更新日期:2016-03-01 00:00:00